SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

The breach that doesn’t have to happen - and what real cyber warfare looks like

"We are able to understand what drives cancer. This changes the entire course of the disease"

Why Disney is licensing AI instead of fighting it

Israeli healthtech faces a more selective funding market after the war

Buzz

Most popular

Daily

Weekly

1

Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”

2

UAE reportedly behind Elbit’s record $2.3 billion defense deal

3

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

4

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

5

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

Nucleai

6 stories about Nucleai

Spatial AI biomarker startup Nucleai raises $14 million led by Merck’s VC arm

Leveraging AI and machine learning, Nucleai analyzes pathology images and spatial data at the cellular and tissue levels. The proprietary technology extracts detailed patterns and features from medical images, offering insights into the tumor microenvironment, cellular morphology, and spatial relationships between different cell types

How have international stakeholders responded to Startup Nation since 7/10?

26.10.23|James Spiro

Nucleai helped its global customers and investors understand the magnitude of October 7 by comparing it to 9/11 in the U.S.

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach

The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs

צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

The Israeli startup using spatial biology to provide better cancer treatment

02.01.22|Yafit Ovadia

Nucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions

צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

AI cancer treatment startup Nucleai raises $6.5 million in series A round

07.07.20|Meir Orbach

Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment

CTech’s Monday Israeli Tech News Roundup

Israel wants to lure U.S. scientists with $100 thousand grants. Barclays ends partnership with Ness Technologies